Disease-Modifying Drugs Reduce Cortical Lesion Accumulation and Atrophy Progression in Relapsing-Remitting Multiple Sclerosis: Results from a 48-Month Extension Study

Cortical lesions (CLs) and atrophy are pivotal in multiple sclerosis (MS) pathology. This study determined the effect of disease modifying drugs (DMDs) on CL development and cortical atrophy progression in patients with relapsing-remitting MS (RRMS) over 48 months. Patients (n = 165) were randomized...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mult Scler Int
Main Authors: Rinaldi, Francesca, Perini, Paola, Atzori, Matteo, Favaretto, Alice, Seppi, Dario, Gallo, Paolo
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4353660/
https://ncbi.nlm.nih.gov/pubmed/25802758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/369348
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados